Improving quality of life for all
We discover the causes of musculoskeletal and inflammatory conditions to deliver excellent and innovative care that improves people’s quality of life.
The Botnar Research Centre enables and encourages research and education into the causes of musculoskeletal disease and their treatment.
Translating Regenerative Biomaterials Into Clinical Practice.
Stace ET. et al, (2016), J Cell Physiol, 231, 36 - 49
The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants.
Tsoumpra MK. et al, (2015), Bone, 81, 478 - 486
Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers.
Cook JA. et al, (2015), Trials, 16
OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy.
Taylor PC. et al, (2015), Ann Rheum Dis, 74, 2123 - 2129